Ding, Y. and Liu, W. 2026. Efficacy and Safety of Xeligekimab Compared to Other IL-17A Inhibitors for Chinese Patients with Moderate-to-severe Plaque Psoriasis: A Matching-adjusted Indirect Comparisons. Acta Dermato-Venereologica. 106, (Apr. 2026), adv–2025. DOI:https://doi.org/10.2340/actadv.v106.adv-2025-0183.